Regardless of the outcome, NTSR1-bearing cells of healthy peripheral tissues can be protected from the deleterious effects of transgene expression using a cell-specific promoter or a tumor-selective promoter, such as the Mucin-1 promoter, to confine the therapeutic effect within the tumorous cells [55]. The gene discussed is NTSR1; the disease is neoplasm.